Filing Details
- Accession Number:
- 0001140361-15-023422
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-05 19:00:29
- Reporting Period:
- 2015-06-04
- Filing Date:
- 2015-06-05
- Accepted Time:
- 2015-06-05 19:00:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
913077 | Affymetrix Inc | AFFX | Laboratory Analytical Instruments (3826) | 770319159 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1455312 | Frank Witney | C/O Affymetrix, Inc. 3420 Central Expressway Santa Clara CA 95051 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-04 | 75,000 | $6.71 | 534,847 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-04 | 75,000 | $11.78 | 459,847 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to Purchase Common Stock | Disposition | 2015-06-04 | 75,000 | $0.00 | 75,000 | $6.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
225,000 | 2018-07-21 | No | 4 | M | Direct |
Footnotes
- Sold pursuant to a 10b5-1 Trading Plan.
- These sales were executed in multiple trades at prices ranging from $11.58 to $11.99. The price reported above reflects the weighted average sales price. The reporting person hereby undetrakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the trnasactions were effected.
- Stock option became exercisable in equal annual installments over four years from the grant date of July 21, 2011.